UPDATE: BofA/Merrill Lynch Upgrades Mindray Medical (MR) to Buy

December 13, 2013 11:42 AM EST Send to a Friend
Get Alerts MR Hot Sheet
Price: $30.71 +9.60%

Rating Summary:
    5 Buy, 11 Hold, 2 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 11 | Down: 19 | New: 16
Trade MR Now!
Join SI Premium – FREE
(Updated - December 13, 2013 1:03 PM EST)

BofA/Merrill Lynch upgraded Mindray Medical (NYSE: MR) from Neutral to Buy with a price target of $40. The company recently held a conference call to answer questions following a negative report by Ottoman Bay Research. In the view of BofA analysts, Mindray management gave solid information on questions regarding its accounting, cash positions and M&A strategy.

For an analyst ratings summary and ratings history on Mindray Medical click here. For more ratings news on Mindray Medical click here.

Shares of Mindray Medical closed at $35.61 yesterday.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories

Hot Upgrades, Short Sales, Trader Talk, Upgrades

Related Entities

Merrill Lynch, Bank of America

Add Your Comment